|

Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

RECRUITINGSponsored by University Hospital, Strasbourg, France
Actively Recruiting
SponsorUniversity Hospital, Strasbourg, France
Started2024-12-04
Est. completion2026-02
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT07313475

Summary

Lupus anticoagulant (LA) testing is performed using two screening tests: activated partial thromboplastin time (APTT) and diluted Russell's viper venom time. If one of the screening tests is positive, a confirmation test based on the same principle is performed. The HUS Hematology Laboratory uses an integrated APTT for LA testing, consisting of a screening reagent: Cephen LS, and a confirmation reagent: Cephen (Hyphen Biomed). The aim of this study is to determine whether another integrated activated partial thromboplastin time (APTT) test, Cryocheck HexLA, offers better performance than Cephen LS/Cephen, both in terms of sensitivity to lupus anticoagulant (LA) and susceptibility to interference from anticoagulant treatments.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Patient of legal age (≥ 18 years)
* Sample sent to the HUS Hematology Laboratory and analyzed for LA detection as part of routine care.

Exclusion Criteria:

\- Insufficient sample volume

Conditions2

LupusLupus Anticoagulant

Browse More Trials

Lupus trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.